Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group  

作　　者：Na Li Wu Fu Jianying Lei Jiahao Zhang Caicong You Jingwen Lin Bin Zheng Maobai Liua 

机构地区：[1]Department of Pharmacy,Fujian Medical University Union Hospital,Fuzhou,350001,China [2]School of Pharmacy,Fujan Medical University,Fuzhou,350122,China

出　　处：《Pharmacoeconomics and Policy》2025年第1期42-50,共9页药物经济与政策(英文)

基　　金：supported by grants from the National Natural Science Foundation of China(Grant No.:71804025);the Development Center for Medical Science&Technology,National Health Commission of the People's Republic of China(Grant No:WKZX2023CX210005).

摘　　要：This study aims to build a value assessment framework applicable to Chinese health-care institutions for antineoplastic agents in the context of diagnosis related group(DRG).This study constructed the value assessment framework through literature research,Delphi expert consultation method,and analytic hierarchy process(AHP).This study used internal consistency reliability to test the reliability of the constructed framework.Exploratory factor analysis(EFA)and validation factor analysis were used for the validity test.Then,the level stratification of the indicators was set based on the literature data,and the value function of each indicator was constructed using the measuring attractiveness by a categorical based assessment technique method to construct a quantitative value assessment model.This study established a value assessment framework of 7 dimensions and 26 indicators.Reliability and validity analyses of these indicators made 4 indicators excluded.Then,the value functions were constructed for 17 indicators,establishing a quantitative value assessment model.This study constructed an antineoplastic drugs evaluation framework in the context of DRG with good validity and reliability and the corresponding quantitative value assessment model.

关 键 词：Diagnosis related group Value assessment framework Multi-criteria decision analysis Antineoplastic agents 

分 类 号：TP3[自动化与计算机技术—计算机科学与技术]